Scientists Identify Novel Genes Linked to Motor Neuron Disease
This study reveals three new risk genes for ALS, and one of these – C21orf2 – increases an individual’s risk of developing the disease by 65 percent. These results could aid the development of personalized treatments for people with ALS by using gene therapy – an approach which involves replacing faulty genes or adding new ones. One in every 400 people will be diagnosed with ALS at some point in their lives, yet its causes are largely unknown and effective treatments are therefore lacking. To read more, click here.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
June 29-30, 2017; Germany
2nd International Conference on Spine and Spinal Disorders
July 24-26, 2017; Rome, Italy
The Society of University Neurosurgeons Annual Meeting
July 27-Aug. 3, 2017; South Africa
Washington University/St. Louis Children’s Comprehensive SEEG Course
Aug. 10-12, 2017; St. Louis